GSK executive acquires notional ADS in savings plan
GSK plc reported that President Maya Martinez-Davis acquired notional American Depositary Shares through a company savings plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
6-K
Rhea-AI Filing Summary
GSK plc reported that President Maya Martinez-Davis acquired notional American Depositary Shares through a company savings plan. The transaction involved 9.4103 ADS at a price of $50.7400 per ADS on the New York Stock Exchange on 2026-06-22, within her GSK Executive Supplemental Savings Plan account.
Key Figures
ADS volume acquired: 9.4103 ADS
ADS price: $50.7400 per ADS
Transaction date: 2026-06-22
+1 more
4 metrics
ADS volume acquired
9.4103 ADS
Notional ADS acquired by President in plan account
ADS price
$50.7400 per ADS
Price for the notional ADS acquisition
Transaction date
2026-06-22
Date of ADS acquisition on NYSE (XNYS)
Instrument identifier
ISIN US37733W2044
American Depositary Shares of GSK plc
Key Terms
PDMR, American Depositary Shares, Executive Supplemental Savings Plan, LEI
4 terms
PDMR regulatory
"Details of PDMR/person closely associated with them ('PCA')"
A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.
Executive Supplemental Savings Plan financial
"Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account"
LEI regulatory
"b) | LEI | 5493000HZTVUYLO1D793"
A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did GSK (GSK) disclose in this 6-K?
GSK disclosed that President Maya Martinez-Davis acquired notional American Depositary Shares. The transaction occurred within her GSK Executive Supplemental Savings Plan account, reflecting 9.4103 ADS at $50.7400 per ADS, and was reported as an initial notification for this acquisition.
Who is the GSK (GSK) executive involved in the reported transaction?
The executive is Maya Martinez-Davis, identified as President at GSK. She is classified as a PDMR, meaning a person discharging managerial responsibilities, and the filing records her acquisition of notional ADS in the GSK Executive Supplemental Savings Plan on the New York Stock Exchange.
What type of security did the GSK (GSK) executive acquire?
Maya Martinez-Davis acquired notional American Depositary Shares, or ADS, of GSK. These ADS are identified with ISIN US37733W2044 and were credited within her GSK Executive Supplemental Savings Plan account rather than through a standard open-market purchase transaction.
What were the price and volume in the GSK (GSK) executive’s ADS transaction?
The transaction covered 9.4103 notional American Depositary Shares at a price of $50.7400 per ADS. This is recorded as a single transaction in the filing, with no aggregation across multiple trades, and occurred on the New York Stock Exchange.
When and where did the GSK (GSK) ADS transaction take place?
The transaction took place on 2026-06-22 on the New York Stock Exchange, identified as XNYS. The filing specifies this as the trading venue where the notional ADS were acquired within the executive’s GSK Executive Supplemental Savings Plan account.
How is this GSK (GSK) insider transaction categorized in the filing?
The transaction is described as an acquisition of notional ADS within Maya Martinez-Davis’s GSK Executive Supplemental Savings Plan account. It is reported as an initial notification and relates to a person discharging managerial responsibilities, highlighting transparency around executive-linked share interests.
AI-generated analysis. How Rhea-AI works. Not financial advice.
